The University of Chicago Header Logo

Connection

Joel Pekow to Drug Substitution

Back to Details
This is a "connection" page, showing publications Joel Pekow has written about Drug Substitution.
Joel Pekow
Connection Strength
0.151
Drug Substitution
  1. Outcome of elective switching to vedolizumab in inflammatory bowel disease patients under tumor necrosis factor antagonist-maintained clinical remission. J Gastroenterol Hepatol. 2019 Dec; 34(12):2090-2095.
    View in: PubMed
    Score: 0.151
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.